Instrumental variables I: instrumental variables exploit natural variation in nonexperimental data to estimate causal relationships
- PMID: 19356901
- PMCID: PMC2905668
- DOI: 10.1016/j.jclinepi.2008.12.005
Instrumental variables I: instrumental variables exploit natural variation in nonexperimental data to estimate causal relationships
Abstract
The gold standard of study design for treatment evaluation is widely acknowledged to be the randomized controlled trial (RCT). Trials allow for the estimation of causal effect by randomly assigning participants either to an intervention or comparison group; through the assumption of "exchangeability" between groups, comparing the outcomes will yield an estimate of causal effect. In the many cases where RCTs are impractical or unethical, instrumental variable (IV) analysis offers a nonexperimental alternative based on many of the same principles. IV analysis relies on finding a naturally varying phenomenon, related to treatment but not to outcome except through the effect of treatment itself, and then using this phenomenon as a proxy for the confounded treatment variable. This article demonstrates how IV analysis arises from an analogous but potentially impossible RCT design, and outlines the assumptions necessary for valid estimation. It gives examples of instruments used in clinical epidemiology and concludes with an outline on estimation of effects.
Similar articles
-
Instrumental variable methods for causal inference.Stat Med. 2014 Jun 15;33(13):2297-340. doi: 10.1002/sim.6128. Epub 2014 Mar 6. Stat Med. 2014. PMID: 24599889 Free PMC article.
-
Instruments for causal inference: an epidemiologist's dream?Epidemiology. 2006 Jul;17(4):360-72. doi: 10.1097/01.ede.0000222409.00878.37. Epidemiology. 2006. PMID: 16755261
-
Profiling compliers and noncompliers for instrumental variable analysis with covariates: A weighting approach.PLoS One. 2023 Jun 15;18(6):e0283223. doi: 10.1371/journal.pone.0283223. eCollection 2023. PLoS One. 2023. PMID: 37319247 Free PMC article.
-
Instrumental variable methods in comparative safety and effectiveness research.Pharmacoepidemiol Drug Saf. 2010 Jun;19(6):537-54. doi: 10.1002/pds.1908. Pharmacoepidemiol Drug Saf. 2010. PMID: 20354968 Free PMC article. Review.
-
A tutorial on the use of instrumental variables in pharmacoepidemiology.Pharmacoepidemiol Drug Saf. 2017 Apr;26(4):357-367. doi: 10.1002/pds.4158. Epub 2017 Feb 27. Pharmacoepidemiol Drug Saf. 2017. PMID: 28239929 Review.
Cited by
-
Mendelian randomization.Nat Rev Methods Primers. 2022 Feb 10;2:6. doi: 10.1038/s43586-021-00092-5. Nat Rev Methods Primers. 2022. PMID: 37325194 Free PMC article.
-
Rate of Intraoperative Crystalloid Administration During Thoracic Surgery Is Causal in Reducing Postoperative Hospital Length of Stay.Ochsner J. 2023 Summer;23(2):106-119. doi: 10.31486/toj.22.0113. Ochsner J. 2023. PMID: 37323526 Free PMC article.
-
Reducing the number and types of tobacco retail outlets in the Netherlands: Study protocol for a comprehensive mixedmethods policy evaluation.Tob Prev Cessat. 2023 Mar 29;9:08. doi: 10.18332/tpc/161825. eCollection 2023. Tob Prev Cessat. 2023. PMID: 37009236 Free PMC article.
-
An Empirical Study of the Pathway Model Link Between Cognitive Distortions and Gambling Problems.J Gambl Stud. 2023 Sep;39(3):1189-1205. doi: 10.1007/s10899-022-10166-y. Epub 2022 Nov 21. J Gambl Stud. 2023. PMID: 36413263
-
High-dimensional propensity scores for empirical covariate selection in secondary database studies: Planning, implementation, and reporting.Pharmacoepidemiol Drug Saf. 2023 Feb;32(2):93-106. doi: 10.1002/pds.5566. Epub 2022 Nov 22. Pharmacoepidemiol Drug Saf. 2023. PMID: 36349471 Free PMC article.
References
-
- Hernan MA, Brumback B, Robins JM. Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men. Epidemiology. 2000;11:561–70. - PubMed
-
- Robins JM. Correcting for non-compliance in randomized trials using structural nested mean models. Commun Statist Theory Meth. 1994;23:2379–412.
-
- Walker AM. Confounding by indication. Epidemiology. 1994;7:335–6. - PubMed
-
- Schneweiss S, Avorn J. A review of uses of health care utilization databases for epidemiologic research on therapeutics. J Clin epidemiol. 2005;58:323–37. - PubMed
-
- Glynn RJ, Schneeweiss S, Wang PS, Levin R, Avorn J. Selective prescribing led to overestimation of the benefits of lipid-lowering drugs. J Clin epidemiol. 2006;59:819–28. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
